Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Mechanisms Of Cerebral Vasospasm In Subarachnoid Haemorrhage.

D. Cook
Published 1995 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Cerebrovascular spasm is a slowly developing constriction of the cerebral arteries, which frequently follows subarachnoid haemorrhage and is associated with considerable morbidity and mortality. The condition has been studied by use of models of subarachnoid haemorrhage in the whole animal and examination of isolated blood vessels or vascular smooth muscle cells in culture. The condition probably arises from the action of haemoglobin released from erythrocytes trapped in the subarachnoid clots, although the mechanism of action of haemoglobin remains uncertain. Systemic pharmacotherapy to avert or reverse vasospasm is still experimental.
This paper references
10.3171/JNS.1992.76.1.0081
Cytoskeletal and extracellular matrix proteins in cerebral arteries following subarachnoid hemorrhage in monkeys.
R. MacDonald (1992)
10.1111/j.1471-4159.1988.tb03077.x
Activation of the Arachidonate 5‐Lipoxygenase Pathway in the Canine Basilar Artery After Experimental Subarachnoidal Hemorrhage
T. Shimizu (1988)
Endothelium-dependent responses in cerebral blood vessels
P. Vanhoutte (1986)
10.3171/JNS.1989.71.6.0909
Pharmacological studies on relaxation of spastic primate cerebral arteries in subarachnoid hemorrhage.
K. Kanamaru (1989)
10.1159/000139048
Production of 15-HETE by cultured smooth muscle cells from cerebral artery.
R. Schulz (1993)
10.3171/JNS.1986.64.4.0617
Effect of nimodipine on intracellular brain pH, cortical blood flow, and EEG in experimental focal cerebral ischemia.
F. Meyer (1986)
10.1016/0090-3019(84)90194-0
Treatment of cerebral vasospasm. Usefulness of Swan-Ganz catheter monitoring of volume expansion.
M. Pritz (1984)
Vascular tone and thromboxane a 2 level in canine cerebral arteries
M. Fujiwara (1987)
10.1152/AJPHEART.1988.255.4.H847
Independent blockade of cerebral vasodilation from acetylcholine and nitric oxide.
J. J. Marshall (1988)
10.1016/0006-291X(90)91243-L
Vascular smooth muscle-derived relaxing factor (MDRF) and its close similarity to nitric oxide.
K. S. Wood (1990)
10.2176/NMC.21.201
The Relation between Cerebral Vasospasms and Superoxide
Kazuyo Kamiyama (1981)
10.1097/00006123-199012000-00010
Accelerated non-muscle contraction after subarachnoid hemorrhage: cerebrospinal fluid testing in a culture model.
Y. Yamamoto (1990)
10.1227/00006123-197811000-00006
Treatment of patients with neurological deficits associated with cerebral vasospasm by intravascular volume expansion.
M. Pritz (1978)
10.1096/fasebj.1.3.3040504
Protein kinase C in the regulation of smooth muscle contraction
H. Rasmussen (1987)
10.1161/01.RES.51.4.439
Heterogeneous Behavior of the Canine Arterial and Venous Wall: Importance of the Endothelium
J. D. De Mey (1982)
10.3171/JNS.1989.70.1.0108
Release of endothelium-derived relaxing factor after subarachnoid hemorrhage.
P. Kim (1989)
10.3171/JNS.1987.67.4.0558
The effect of timing of clot removal on chronic vasospasm in a primate model.
Y. Handa (1987)
10.1227/00006123-198209000-00001
Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension.
N. Kassell (1982)
10.3171/JNS.1974.40.4.0433
Cerebral arterial spasm.
G. Allen (1985)
Cerebral arterial spasm. Part 8: The treatment of delayed cerebral arterial spasm in human beings.
Allen Gs (1976)
10.1016/s0021-9258(18)60979-2
Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation.
J. M. Braughler (1987)
10.1161/01.STR.8.4.480
Cerebral Arterial Smooth Muscle Contraction by Thromboxane A2
E. Ellis (1977)
10.1161/01.STR.13.4.473
Angiographic study of vasospasm following subarachnoid hemorrhage in monkeys.
S. Peerless (1982)
10.1161/01.STR.10.1.26
Intravenous Nitroglycerin in Experimental Cerebral Vasospasm. A Preliminary Report
J. Kistler (1979)
10.1097/00006123-198112000-00011
Prevention of cerebral ischemic symptoms in cerebral vasospasm with trapidil, an antagonist and selective synthesis inhibitor of thromboxane A2.
S. Suzuki (1981)
10.3171/JNS.1983.58.1.0011
Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a "two-hemorrhage" canine model.
V. Varsos (1983)
10.1016/0005-2744(73)90180-0
Generation of superoxide radicals during the autoxidation of mammalian oxyhemoglobin
R. Wever (1973)
10.3171/JNS.1992.76.1.0111
Effects of inhibitors of protein kinase C and calpain in experimental delayed cerebral vasospasm.
N. Minami (1992)
10.3171/JNS.1980.53.4.0486
Dose responses of cerebral arteries of the dog, rabbit, and man to human hemoglobin in vitro.
G. R. Wellum (1980)
10.1227/00006123-198502000-00001
Nimodipine and chronic vasospasm in monkeys: Part 1. Clinical and radiological findings.
M. Nosko (1985)
10.1161/01.STR.21.4.577
Chronic cerebral blood flow changes following experimental subarachnoid hemorrhage in rats.
A. Kader (1990)
10.1227/00006123-198110000-00010
Effects of various intracranial fluids on smooth muscle.
F. Okwuasaba (1981)
10.1159/000158495
Characterization of the thrombin-induced contraction of vascular smooth muscle.
V. Haver (1984)
Endothelium-derived relaxing factors
P. Vanhoutte (1995)
10.1161/01.STR.17.3.501
Effect of nimodipine on cerebral functional and metabolic recovery following ischemia in the rat brain.
H. Mabe (1986)
10.1111/J.1365-2125.1978.TB04586.X
Aetiology of cerebral arterial spasm following subarachnoid haemorrhage: evidence against a major involvement of 5-hydroxy-tryptamine in the production of acute spasm.
D. Boullin (1978)
10.3171/JNS.1981.54.3.0357
The effect of a lipid hydroperoxide of arachidonic acid on the canine basilar artery. An experimental study on cerebral vasospasm.
T. Sasaki (1981)
10.1152/AJPHEART.1985.248.4.H432
Endothelium-dependent contractions to arachidonic acid are mediated by products of cyclooxygenase.
V. Miller (1985)
10.1159/000137986
The pharmacology of cerebral vasospasm.
D. Cook (1984)
10.1227/00006123-198806010-00009
Protein kinase activity in canine basilar arteries after subarachnoid hemorrhage.
Y. Suzuki (1988)
10.1227/00006123-198002000-00016
Attempted prevention or treatment of intracranial arterial spasm: a survey.
R. Wilkins (1980)
10.1161/01.HYP.16.2.162
H2O2 and endothelium-dependent cerebral arteriolar dilation. Implications for the identity of endothelium-derived relaxing factor generated by acetylcholine.
E. P. Wei (1990)
10.3171/JNS.1982.57.2.0224
Chronic cerebral vasospasm after large subarachnoid hemorrhage in monkeys.
F. Espinosa (1982)
10.1139/Y90-123
Cerebral arteries can generate 5- and 15-hydroxyeicosatetraenoic acid from arachidonic acid.
R. Schulz (1990)
Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta.
W. Martin (1985)
10.3171/JNS.1979.51.2.0164
Effect of nonsteroid anti-inflammatory drugs on subarachnoid hemorrhage in dogs.
R. P. White (1979)
10.3171/JNS.1984.61.5.0857
Effects of chlorpromazine on experimental delayed cerebral vasospasm.
M. Nakano (1984)
10.3171/JNS.1984.60.6.1167
A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part 1: Clinical and radiological findings.
F. Espinosa (1984)
10.1161/01.STR.16.4.562
Cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
N. Kassell (1985)
10.1161/01.STR.15.2.288
The Angiopathy of Subarachnoid Hemorrhage I. Role of Vessel Wall Catecholamines
J. Yoshioka (1984)
10.1227/00006123-198001000-00001
Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning.
C. Fisher (1980)
10.3171/JNS.1988.69.1.0092
Experimental vasospasm in cultured arterial smooth-muscle cells. Part 1: Contractile and ultrastructural changes caused by oxyhemoglobin.
S. Fujii (1988)
10.1227/00006123-198609000-00002
Reactivity of rabbit basilar artery to alterations in extracellular potassium and calcium after subarachnoid hemorrhage.
H. Young (1986)
10.1161/01.STR.10.4.375
Role of Adrenergic Nerves in Blood-Induced Cerebral Vasospasm
F. A. Simeone (1979)
10.3171/JNS.1965.22.1.0021
RUPTURED INTRACRANIAL ANEURYSMS--THE ROLE OF ARTERIAL SPASM.
J. M. Allcock (1965)
10.3171/JNS.1988.68.4.0505
Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial.
K. Petruk (1988)
10.3171/JNS.1977.47.3.0403
Prolonged vasospasm produced by the breakdown products of erythrocytes.
K. Osaka (1977)
10.3171/JNS.1986.64.3.0445
Selective hemoglobin inhibition of endothelium-dependent vasodilation of rabbit basilar artery.
S. Fujiwara (1986)
10.1227/00006123-198606000-00026
Attempts at Prevention or Treatment of Intracranial Arterial Spasm: An Update
R. Wilkins (1986)
10.3171/JNS.1984.60.6.1176
A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part 2: Pathological findings.
F. Espinosa (1984)
10.3171/JNS.1981.55.5.0771
Evaluation of prostaglandin biosynthetic activity in canine basilar artery following subarachnoid injection of blood.
T. Sasaki (1981)
10.3171/JNS.1988.69.4.0593
Bilirubin and the induction of intracranial arterial spasm.
T. Duff (1988)
10.1038/361315A0
Inositol trisphosphate and calcium signalling
M. Berridge (1993)
10.3171/JNS.1983.58.1.0018
Cerebral arterial constriction after experimental subarachnoid hemorrhage is associated with blood components within the arterial wall.
T. Liszczak (1983)
Cerebral vessels in spasm show an enhanced response to calmodulin antagonists.
M. Doi (1992)
10.1038/288373A0
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
R. Furchgott (1980)
10.3171/JNS.1986.65.1.0080
The effects of HA compound calcium antagonists on delayed cerebral vasospasm in dogs.
M. Takayasu (1986)
10.1016/0968-0004(86)90207-0
Iron and free radical reactions: two aspects of antioxidant protection
B. Halliwell (1986)
10.1227/00006123-198902000-00005
A trial of the 21-aminosteroid U74006F in a primate model of chronic cerebral vasospasm.
D. Steinke (1989)
10.1227/00006123-198904000-00002
Safety and efficacy of intrathecal thrombolytic therapy in a primate model of cerebral vasospasm.
J. Findlay (1989)
10.3171/JNS.1978.49.2.0229
Cerebral vasospasm and ultrastructural changes in cerebral arterial wall. An experimental study.
Y. Tanabe (1978)
10.1097/00006123-199210000-00014
Relation between protein kinase C and calmodulin systems in cerebrovascular contraction: investigation of the pathogenesis of vasospasm after subarachnoid hemorrhage.
S. Nishizawa (1992)
10.3171/JNS.1978.48.1.0049
Ultrastructural changes in feline arterial endothelium following subarachnoid hemorrhage.
M. Mayberg (1978)
10.1227/00006123-197901000-00008
Cerebral arterial spasm: part 10. Reversal of acute and chronic spasm in dogs with orally administered nifedipine.
G. Allen (1979)
A new vasoconstrictor peptide, endothelin: profiles as vasoconstrictor and neuropeptide.
T. Shigeno (1990)
10.3171/JNS.1983.59.2.0223
Correlation between angiographic vasospasm, hematoma, and ischemic brain damage following SAH.
D. Graham (1983)
10.1159/000158159
Pharmacological in vitro analysis of amine-mediated vasomotor functions in the intracranial and extracranial vascular beds.
C. Owman (1978)
10.1161/01.STR.17.2.196
Biological defence mechanism in the pathogenesis of prolonged cerebral vasospasm in the patients with ruptured intracranial aneurysms.
S. Sakaki (1986)
10.1161/01.STR.10.6.703
Experimental Cerebral Vasospasm after Subarachnoid Hemorrhage Participation of Adrenergic Nerves in Cerebral Vessel Wall
S. Endo (1979)
10.1016/0165-6147(91)90617-2
Receptor-coupled phospholipase D and its inhibition.
N. Thompson (1991)
10.1161/01.STR.18.5.938
Endothelium-dependent relaxation of canine basilar arteries. Part 2: Inhibition by hemoglobin and cerebrospinal fluid from patients with aneurysmal subarachnoid hemorrhage.
K. Kanamaru (1987)
10.1017/S0317167100045340
Rupture of an experimentally induced aneurysm in a primate.
F. Espinosa (1984)
10.3171/JNS.1974.40.4.0442
Cerebral arterial spasm. 2. In vitro contractile activity of serotonin in human serum and CSF on the canine basilar artery, and its blockage by methylsergide and phenoxybenzamine.
G. Allen (1974)
10.1016/0014-5793(90)81284-U
Protein kinase C in transmembrane signalling
A. Farago (1990)
10.1038/332411A0
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
M. Yanagisawa (1988)
10.3171/JNS.1980.53.3.0312
Mechanism of cerebral arterial contraction induced by blood constituents.
N. Toda (1980)
10.1016/0014-2999(80)90381-7
Synaptic transmission of vasoconstrictor nerves in rabbit basilar artery.
T. J. Lee (1980)
10.3171/JNS.1982.56.6.0777
Cerebral vasoactivity of heme proteins in vitro. Some mechanistic considerations.
G. R. Wellum (1982)
10.3171/JNS.1992.76.4.0635
Direct evidence for a key role of protein kinase C in the development of vasospasm after subarachnoid hemorrhage.
S. Nishizawa (1992)
10.1093/BRAIN/93.3.475
Innervation of intracranial arteries.
E. Nelson (1970)
10.1378/CHEST.88.4_SUPPLEMENT.220S
Calcium kinetics in vascular smooth muscle.
G. Weiss (1985)
10.1016/0006-291X(90)91422-O
Hemoglobin causes release of inositol trisphosphate from vascular smooth muscle.
B. Vollrath (1990)
10.3171/JNS.1978.48.4.0515
Cerebral artery spasm. A histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage.
J. T. Hughes (1978)
10.1161/01.STR.16.2.262
Constricting effect of leukotrienes on cerebral arterioles of mice.
W. Rosenblum (1985)
10.3171/JNS.1991.74.6.0951
Longitudinal time course of reversible and irreversible components of chronic cerebrovasospasm of the rabbit basilar artery.
P. Vorkapic (1991)
10.1161/01.STR.22.3.384
Development of a new perfusion system for pharmacological study on rabbit basilar arteries.
T. Ohta (1991)
10.3171/JNS.1991.75.1.0082
Altered reactivity of hemolysate-treated cultured smooth-muscle cells from rabbit basilar artery determined by digital imaging microscopy.
Y. Takanashi (1991)
10.3171/JNS.1982.56.3.0339
Effect of fibrin-fibrinogen degradation products on human basilar artery preparations.
R. Lye (1982)
10.3171/JNS.1974.40.4.0451
Cerebral arterial spasm. 3. In vivo intracisternal production of spasm by serotonin and blood and its reversal by phenoxybenzamine.
G. Allen (1974)
10.1227/00006123-199203000-00006
Time course of changes in concentration of intracellular free calcium in cultured cerebrovascular smooth muscle cells exposed to oxyhemoglobin.
Y. Takanashi (1992)
10.3171/JNS.1989.71.5.0741
Activated complement components C3a and C4a in cerebrospinal fluid and plasma following subarachnoid hemorrhage.
H. Kasuya (1989)
10.3171/JNS.1991.74.3.0454
Effect of 21-aminosteroid U-74006F on lipid peroxidation in subarachnoid clot.
K. Kanamaru (1991)
10.3171/JNS.1988.69.5.0723
Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH.
J. Findlay (1988)
10.1136/jnnp.39.8.756
Evidence for the presence of a vasoactive substance (possibly involved in the aetiology of cerebral arterial spasm) in cerebrospinal fluid from patients with subarachnoid haemorrhage.
D. Boullin (1976)
10.1017/S0317167100020084
Relative prognostic significance of vasospasm following subarachnoid hemorrhage.
B. Weir (1975)
10.1227/00006123-198402000-00013
Effect of reserpine-kanamycin treatment on chronic vasospasm after platelet-enriched subarachnoid hemorrhage in primates.
T. Noseworthy (1984)
10.1159/000158143
Reactivity of isolated human cerebral arteries to biogenic amines.
S. Shibata (1977)
10.1161/01.STR.12.6.775
Changes in vasoactive properties of blood products with time and attempted identification of the spasmogens.
F. Okwuasaba (1981)
10.1097/00006123-199008000-00014
Blood component induction of cerebral vasospasm.
T. Harada (1990)
10.1161/01.STR.19.11.1420
Experimental model of symptomatic vasospasm in rabbits.
S. Endo (1988)
10.1227/00006123-198602000-00002
Chronic cerebral vasospasm: effect of calcium antagonists.
J. Zabramski (1986)
10.1016/0306-3623(82)90100-8
Nerve endings and pharmacological receptors in cerebral vessels.
J. Marín (1982)
10.3171/JNS.1978.48.2.0173
Time course of vasospasm in man.
B. Weir (1978)
10.1161/01.STR.20.1.105
Effect of nimodipine on canine cerebrovascular responses to 5-hydroxytryptamine and potassium chloride after exposure to blood.
T. Tsuji (1989)
10.1227/00006123-198609000-00005
Elevation of brain norepinephrine concentration after experimental subarachnoid hemorrhage
R. Solomon (1986)
10.1227/00006123-198605000-00025
Profound cerebral vasospasm without radiological evidence of subarachnoid hemorrhage: case report.
M. Grady (1986)
10.1097/00006123-198912000-00010
The calmodulin antagonist trifluoperazine provides mild prophylactic protection against cerebral vasospasm after subarachnoid hemorrhage, but no therapeutic value.
J. W. Peterson (1989)
10.1161/01.STR.15.2.295
Responses of Isolated Canine Basilar Artery and Human29S Platelet to Chlorpromazine and Amitriptyline
Eiichj Tani (1984)
10.3171/JNS.1979.50.4.0441
Cerebrovascular responses to subarachnoid blood and serotonin in the monkey.
D. Boisvert (1977)
10.1161/01.STR.15.2.306
Effect of Selective Inhibitor of Thromboxane A2 Synthetase on Experimental Cerebral Vasospasm
T. Fukumori (1984)
5-Hydroxytryptamine and vasospasm induced by subarachnoid hemorrhage.
F. K. Okawuasaba (1979)
10.1227/00006123-198607000-00003
Modification of experimental post-subarachnoid hemorrhage vasculopathy with intracisternal plasmin.
J. Alksne (1986)
10.1161/01.STR.20.4.527
Biosynthesis of leukotrienes in canine cerebral vasospasm.
M. Yokota (1989)
10.3171/JNS.1980.53.6.0787
Cerebral vasospasm: contractile activity of hemoglobin in isolated canine basilar arteries.
T. Tanishima (1980)
10.1126/SCIENCE.1411571
Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C.
Y. Nishizuka (1992)
10.1042/BJ2490185
Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Is haemoglobin a biological Fenton reagent?
A. Puppo (1988)
10.3171/JNS.1981.55.6.0877
Effects of indomethacin and prostacyclin on isolated human pial arteries contracted by CSF from patients with aneurysmal SAH.
L. Brandt (1981)
10.1227/00006123-198204000-00019
Timing of aneurysm surgery.
N. F. Kassell (1982)
10.3171/JNS.1992.76.5.0830
The effect of chronic subarachnoid hemorrhage on basal endothelium-derived relaxing factor activity in intrathecal cerebral arteries.
D. Edwards (1992)
Possible mechanisms of 15-hydroperoxyarachidonic acid-induced contraction of the canine basilar artery in vitro.
T. Koide (1982)
10.1161/01.RES.68.2.416
Free radicals mediate actions of oxyhemoglobin on cerebrovascular smooth muscle cells.
J. Steele (1991)
10.1161/01.STR.23.10.1527
Endothelium‐Derived Relaxing Factor in Brain Blood Vessels Is Not Nitric Oxide
W. Rosenblum (1992)
10.1146/ANNUREV.PH.48.030186.001343
Prostaglandin biosynthesis and its compartmentation in vascular smooth muscle and endothelial cells.
W. Smith (1986)
10.1097/00005344-199204002-00031
Biphasic Response to Substance P in Canine Basilar Arteries
T. Tsuji (1992)
10.1016/0160-5402(84)90062-7
Detection of endothelium in cerebral blood vessels.
R. P. Abrol (1984)
10.1161/01.STR.9.2.133
Prolonged Contraction of Isolated Human and Canine Cerebral Arteries Induced by Uridine 5'-Triphosphate
P. Urquilla (1978)
10.1097/00006123-199009000-00003
Effect of Endothelin on the Canine Basilar Artery
H. Kobayashi (1990)
10.1016/s0021-9258(19)44679-6
The generation of superoxide radical during the autoxidation of hemoglobin.
H. Misra (1972)
10.3171/JNS.1986.65.3.0376
Effects of nimodipine on in vitro contractility of cerebral arteries of dog, monkey, and man.
M. Nosko (1986)
10.1227/00006123-198102000-00020
Origin, growth, and rupture of saccular aneurysms: a review.
L. Sekhar (1981)
10.3171/JNS.1984.61.3.0486
Morphological changes of the basilar artery, ventricles, and choroid plexus after experimental SAH.
T. Liszczak (1984)
10.3171/JNS.1978.48.2.0179
Intercellular granules and vesicles in prolonged cerebral vasospasm.
E. Tani (1978)
10.1227/00006123-197901000-00007
Cerebral arterial spasm: part 9. In vitro effects of nifedipine on serotonin-, phenylephrine-, and potassium-induced contractions of canine basilar and femoral arteries.
G. Allen (1979)
Effects of hemoglobin on smooth muscle.
D. Cook (1979)
10.1159/000158490
Comparison of responses elicited by alpha-thrombin in isolated canine basilar, coronary, mesenteric, and renal arteries.
R. P. White (1984)
10.3171/JNS.1992.77.5.0763
Inhibition of delayed arterial narrowing by the iron-chelating agent deferoxamine.
T. Harada (1992)
10.1159/000158682
A possible role of thromboxane A2 in endothelium in maintaining resting tone and producing contractile response to acetylcholine and arachidonic acid in canine cerebral arteries.
H. Shirahase (1987)
10.3171/JNS.1988.69.2.0263
Potentiating effects of extraluminal oxyhemoglobin to intraluminal 5-hydroxytryptamine in isolated canine internal carotid arteries.
Y. Tanaka (1988)
Bilirubin. Solubility and interaction with albumin and phospholipid.
R. Brodersen (1979)
10.1161/01.STR.19.12.1550
Comparison of intraluminal and extraluminal inhibitory effects of hemoglobin on endothelium-dependent relaxation of rabbit basilar artery.
K. Hongo (1988)
10.1038/jcbfm.1988.1
Free Radical Reaction and Biological Defense Mechanism in the Pathogenesis of Prolonged Vasospasm in Experimental Subarachnoid Hemorrhage
S. Sakaki (1988)
10.1016/0968-0004(90)90206-Q
The measurement and mechanism of lipid peroxidation in biological systems.
J. Gutteridge (1990)
10.1016/0003-9861(86)90305-X
Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts.
B. Halliwell (1986)
Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs.
R. Furchgott (1953)
10.1227/00006123-199204000-00010
Effect of intrathecal superoxide dismutase and catalase on oxyhemoglobin-induced vasospasm in monkeys.
R. Macdonald (1992)
10.3171/JNS.1987.66.6.0915
Effect of subarachnoid hemorrhage on endothelium-dependent vasodilation.
T. Nakagomi (1987)
10.1161/01.STR.18.5.932
Endothelium-dependent relaxation of canine basilar arteries. Part 1: Difference between acetylcholine- and A23187-induced relaxation and involvement of lipoxygenase metabolite(s).
K. Kanamaru (1987)
Aneurysms affecting the nervous system
B. Weir (1987)
Intracranial vasospasm: a study with iron compounds.
Fox Jl (1979)
Vascular smooth muscle in culture
J. Campbell (1987)
10.1159/000158896
Morphometric analysis of monkey cerebral arteries exposed in vivo to whole blood, oxyhemoglobin, methemoglobin, and bilirubin.
R. MacDonald (1991)
10.1161/01.RES.70.2.248
Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage.
P. Kim (1992)
10.1056/NEJM198303173081103
Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage.
G. Allen (1983)
10.3171/JNS.1980.53.4.0477
Effect of experimental subarachnoid hemorrhage on the adrenergic innervation of cerebral arteries.
R. Lobato (1980)
10.1097/00006123-199009000-00002
A rat femoral artery model for vasospasm.
Tomohisa Okada (1990)
10.1161/01.STR.9.1.25
Effect of Topically Applied Serotonin on Local Cerebral Blood Flow
A. N. Martins (1978)
10.3171/JNS.1994.80.1.0001
The golden anniversary celebration of the Journal
J. A. Jane (1994)
10.1111/J.1365-2125.1979.TB00914.X
Responses of human and baboon arteries to prostaglandin endoperoxides and biologically generated and synthetic prostacyclin: their relevance to cerebral arterial spasm in man.
D. Boullin (1979)
10.1227/00006123-198502000-00002
Nimodipine and chronic vasospasm in monkeys: Part 2. Pharmacological studies of vessels in spasm.
C. Krueger (1985)
10.1038/327524A0
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
R. M. Palmer (1987)
10.3171/JNS.1991.75.3.0415
Etiology of cerebral vasospasm in primates.
R. MacDonald (1991)
10.1055/S-2008-1054106
Pharmacology of nimodipine, a calcium antagonist with preferential cerebrovascular activity.
S. Kazda (1985)
10.3171/JNS.1980.53.4.0480
Cerebrovascular reactivity to noradrenaline and serotonin following experimental subarachnoid hemorrhage.
R. Lobato (1980)
10.1161/01.STR.17.3.494
Endothelial dependent relaxation demonstrated in vivo in cerebral arterioles.
W. Rosenblum (1986)
10.1111/j.1749-6632.1989.tb22604.x
Cerebrospinal Fluid Eicosanoids as an Index of Cerebrovascular Status a
R. P. White (1989)
10.1159/000138525
Time-dependent effects of extraluminally-applied oxyhemoglobin and endothelial removal on vasodilator responses in isolated, perfused canine basilar arteries.
T. Tsuji (1989)
10.1016/0090-3019(87)90037-1
Arachidonic acid metabolism following aneurysm rupture evaluation of cerebrospinal fluid and serum concentration of 6-keto-prostaglandin F1α and thromboxane B2 in patients with subarachnoid hemorrhage
V. Seifert (1987)
Neural regulation of brain circulation
C. Owman (1986)
10.3171/JNS.1951.8.6.0660
Arteriographic demonstration of spasm of the intracranial arteries, with special reference to saccular arterial aneurysms.
A. Ecker (1951)
10.1111/j.1476-5381.1978.tb09754.x
MODELS FOR INVESTIGATING THE AETIOLOGY OF CEREBRAL ARTERIAL SPASM: COMPARATIVE RESPONSES OF THE HUMAN BASILAR ARTERY WITH RAT COLON, ANOCOCCYGEUS, STOMACH FUNDUS, AND AORTA AND GUINEA‐PIG ILEUM AND COLON
D. Boullin (1978)
10.1227/00006123-198801010-00007
Effects of vasospasm on levels of prostacyclin and thromboxane A2 in cerebral arteries of the monkey.
M. Nosko (1988)
10.1111/j.1600-0404.1986.tb03238.x
Prostacyclin and vasospasm in subarachnoid hemorrhage from ruptured intracranial aneurysm
P. Gaetani (1986)
10.3171/JNS.1976.44.5.0585
Cerebral arterial spasm. Part 4: in vitro effects of temperature, serotonin analogues, large nonphysiological concentrations of serotonin, and extracellular calcium and magnesium on serotonin-induced contractions of the canine basilar artery.
G. Allen (1976)
10.1111/j.1476-5381.1986.tb11157.x
The mechanisms by which haemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilators, nitric oxide, or bovine retractor penis inhibitory factor
W. Martin (1986)
10.3171/JNS.1981.55.5.0779
Prostaglandin metabolism in experimental cerebral vasospasm.
Y. Maeda (1981)
10.3171/JNS.1982.57.1.0074
Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581.
T. Sasaki (1982)
10.1161/01.STR.19.10.1257
Calcium channel blockers correct acidosis in ischemic rat brain without altering cerebral blood flow.
L. Berger (1988)
10.1016/0090-3019(87)90280-1
Angiographic evidence of basilar artery constriction in the rabbit: a new model of vasospasm.
K. Baker (1987)
10.1080/01616412.1988.11739836
Relation of supersensitivity to cerebral vasospasm induced by oxyhaemoglobin.
R. Iwai (1988)



This paper is referenced by
CEREBROSPINAL FLUID CALCIUM, APOE PROTEIN AND GENOTYPE IN INDIVIDUALS WITH AND WITHOUT CEREBRAL VASOSPASM AFTER SUBARACHNOID HEMORRHAGE
S. Alexander (2004)
10.1038/sj.jcbfm.9600101
Bilirubin Production and Oxidation in CSF of Patients with Cerebral Vasospasm after Subarachnoid Hemorrhage
G. Pyne-Geithman (2005)
10.33588/RN.3001.99450
Hemorragia subaracnoidea, isquemia cerebral y endotelina-1
J. Secades (2000)
10.2176/NMC.47.537
Effect of raloxifene on cerebral vasospasm following experimental subarachnoid hemorrhage in rats.
S. Gulsen (2007)
10.3171/JNS.2007.106.5.881
Neurokinin-1 receptor antagonism in a rat model of subarachnoid hemorrhage: prevention of upregulation of contractile ETB and 5-HT1B receptors and cerebral blood flow reduction.
S. Ansar (2007)
10.1111/j.1440-1681.2004.03986.x
PARTICIPATION OF VASOPRESSIN IN THE DEVELOPMENT OF CEREBRAL VASOSPASM IN A RAT MODEL OF SUBARACHNOID HAEMORRHAGE
C. Trandafir (2004)
ROLE OF CYTOCHROME P450 FATTY ACID METABOLISM IN THE PATHOPHYSIOLOGY OF SUBARACHNOID HEMORRHAGE
Mark K. Donnelly (2014)
10.1161/01.CIR.0000142615.88444.31
Potential Role for Heat Shock Protein 72 in Antagonizing Cerebral Vasospasm After Rat Subarachnoid Hemorrhage
H. Nikaido (2004)
10.1080/01616412.1998.11740486
Contractions induced by NO synthase inhibition in isolated rat basilar artery: role of the endothelium and endogenous vasoconstrictors.
R. G. Hempelmann (1998)
10.3171/2008.6.17622
Attenuation of cerebral vasospasm and secondary injury by 17beta-estradiol following experimental subarachnoid hemorrhage.
C. Lin (2009)
10.1152/ajpheart.1999.277.5.H1718
Impaired cerebral vasodilator responses to NO and PDE V inhibition after subarachnoid hemorrhage.
C. Sobey (1999)
10.1152/ajpheart.1999.277.5.H1718
Impaired cerebral vasodilator responses to NO and PDE V inhibition after subarachnoid hemorrhage.
C. Sobey (1999)
10.3171/JNS.2002.97.2.0408
Expression of members of the calcium-binding S-100 protein family in a rat model of cerebral basilar artery vasospasm.
F. Lefranc (2002)
10.2165/00003495-200464190-00001
Reactive Oxygen Species in the Cerebral Circulation
T. Paravicini (2012)
10.1016/j.jss.2013.01.033
17β-Estradiol attenuates secondary injury through activation of Akt signaling via estrogen receptor alpha in rat brain following subarachnoid hemorrhage.
Cheng-Hsing Kao (2013)
10.1161/01.STR.28.2.392
Effect of subarachnoid hemorrhage on cerebral vasodilatation in response to activation of ATP-sensitive K+ channels in chronically hypertensive rats.
C. Sobey (1997)
10.1124/PR.55.2.3
The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels
N. Toda (2003)
The Effect Of Resveratrol On Vasospasm In Experimental Triple Subarachnoid Hemorrhage Model
F. Torun (2008)
10.1179/016164106X152007
Endothelin-converting enzyme inhibitors for the treatment of subarachnoid hemorrhage-induced vasospasm
C. Lin (2006)
10.1007/978-3-642-56225-9_70
Intracranial Aneurysms: The Surgical and Endovascular Approach
E. Donauer (2002)
10.1186/1471-2202-12-107
Inhibition of cerebrovascular raf activation attenuates cerebral blood flow and prevents upregulation of contractile receptors after subarachnoid hemorrhage
S. Ansar (2011)
10.1007/s007010170140
The Stimulation of Vascular Smooth Muscle Oxidative Metabolism by CSF from Subarachnoid Haemorrhage Patients Increases with Fisher and WFNS Grades
T. Cadoux-Hudson (2001)
The clinical value of assessing cerebral ischemia : emphasis on brain tissue oxygenation and function of the cerebral microcirculation
F. Pennings (2007)
10.1007/BF02751003
Interactions between vasoconstrictors in isolated human cerebral arteries
R. G. Hempelmann (2007)
10.1007/978-0-387-30383-3_13
Molecular Mechanisms for Early Brain Injury After Subarachnoid Hemorrhage
R. Ostrowski (2007)
10.1097/00006123-200003000-00001
Molecular keys to the problems of cerebral vasospasm.
H. Dietrich (2000)
10.1046/j.1440-1681.2003.03920.x
Cerebral vascular effects of reactive oxygen species: Recent evidence for a role of NADPH‐oxidase
T. Paravicini (2003)
10.1002/(SICI)1097-0185(199804)253:2<58::AID-AR9>3.0.CO;2-A
Stroke: Anatomy of a catastrophic event
J. Zhang (1998)
10.1179/016164104225015967
Characterization of the potent combined endothelin(A/B)-antagonist PD 142893 on cerebral vessels
M. Zimmermann (2004)
10.1016/j.surneu.2007.07.052
Lamotrigine attenuates cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits.
H. Seçkin (2008)
10.3934/Neuroscience.2019.4.316
Elucidating the novel biomarker and therapeutic potentials of High-mobility group box 1 in Subarachnoid hemorrhage: A review
S. Richard (2019)
10.1139/Y96-127
Mechanism of the contractile effect of diaspirin-cross-linked hemoglobin in rat isolated aorta strip denuded of endothelium as revealed using an oil-immersion procedure.
F. Rioux (1996)
See more
Semantic Scholar Logo Some data provided by SemanticScholar